LPTX icon

Leap Therapeutics
LPTX

Overview Fund Activity

46 hedge funds and large institutions have $28.9M invested in Leap Therapeutics in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 9 reducing their positions, and 6 closing their positions.

Holders
46
Holders Change
+2
Holders Change %
+4.55%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
18
Reduced
9
Closed
6
Calls
$43K
Puts
$16K
Net Calls
+$27K
Net Calls Change
+$22K

Top Buyers

1
Balyasny Asset Management
1
Balyasny Asset Management
Illinois
$6.08M
2
SB
2
Samsara BioCapital
California
$4.79M
3
6CM
3
683 Capital Management
New York
$2.55M
4
LCM
4
Laurion Capital Management
New York
$1.39M
5
RSCM
5
Rock Springs Capital Management
Maryland
$2.48M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$223K
2
BC
2
BIT Capital
Germany
$159K
3
ACP
3
Acuta Capital Partners
California
$382K
4
LGM
4
Logos Global Management
California
$0
5
XT
5
XTX Topco
Cayman Islands
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Group One Trading
51
Group One Trading
Illinois
– – -811 Closed
Wells Fargo
52
Wells Fargo
California
– – -152 Closed
CFGS
53
Concourse Financial Group Securities
Alabama
– – – –
1 2
3